OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
Terminated · Phase 3 · NCT06420297
Conditions: Hyperphagia in Prader-Willi Syndrome
At a glance
- Research payments reported, 2025
- $2.4M
- U.S. investigators named
- 20
- Sites paid
- 24
- Planned or actual enrollment
- 168
About the trial
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Tested
- Carbetocin (drug)
- Dates
- Started 2024-03-11; completion 2025-12-19
- Results posted
- Not yet
To evaluate long-term safety and tolerability of carbetocin nasal spray (3.2 mg TID) in subjects with PWS
From ClinicalTrials.gov, last updated 2026-08-17. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Acadia Pharmaceuticals Inc reported $2.4M in research payments for this study in 2025 (162 payments).
Products named: Acp-101
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Parisa Salehi, M.D. Pediatric Endocrinology · Fairbanks, AK
- Hussein D. Abdul-latif, M.D. Pediatric Endocrinology · Birmingham, AL
- Oliver J. Oatman, DO Pediatric Endocrinology · Phoenix, AZ
- Lynne M. Bird, M.D. Medical Genetics · San Diego, CA
- Virginia E. Kimonis, MD Medical Genetics · Orange, CA
- Diane E. Stafford, M.D. Pediatric Endocrinology · Palo Alto, CA
- Shawn E. Mccandless, MD Medical Genetics · Aurora, CO
- Michael J. Tansey, MD Pediatric Endocrinology · Iowa City, IA
- Jill Samis, MD Pediatric Endocrinology · Chicago, IL
- Melissa D. Lah, MD Clinical Molecular Genetics · Indianapolis, IN
- Charumathi Baskaran, MD Pediatric Endocrinology · Boston, MA
- Jennifer L. Heithaus, MD Developmental-Behavioral Pediatrics · Saint Louis, MO
- Emily Paprocki, D.O. Pediatric Endocrinology · Kansas City, MO
- Deepan Singh, M.D. Psychiatry · Glen Oaks, NY
- Kathryn S. Obrynba, M.D. Pediatric Endocrinology · Columbus, OH
- Gerard Vockley, MD, PHD Specialist · Pittsburgh, PA
- Italo Biaggioni, MD Clinical Pharmacology · Nashville, TN
- Kathy Hwu, MD Pediatric Endocrinology · Houston, TX
- Sani A. Roy, M.D. Pediatric Endocrinology · Fort Worth, TX
- David H. Viskochil, MD Medical Genetics · Salt Lake City, UT
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- The Regents of the University of California $427,307
- Vanderbilt University Medical Center, TN $258,597
- University of Alabama Hospital, AL $218,395
- Boston Children's Hospital, MA $191,153
- University of Utah Hospital and Clinics, UT $161,046
- Baylor College of Medicine $106,583
- Children's Hospital Colorado, CO $100,884
- University of Iowa Hospital & Clinics, IA $84,252
- University of Pittsburgh Physicians $82,989
- Phoenix Children's Hospital, AZ $82,969
- St Louis University $81,370
- Ann & Robert H Lurie Childrens Hospital of Chicago, IL $78,891
- Board of Trustees of the Leland Stanford Junior University $77,774
- Maimonides Medical Center, NY $71,431
- The Research Institute at Nationwide Children's Hosp $64,467
- Trustees of Indiana University $59,442
- Uci Health-Orange, CA $57,372
- UPMC Children's Hospital of Pittsburgh, PA $54,415
- Cook Children S Health Care System $47,400
- The Children's Mercy Hospital, MO $45,630
- The University of Iowa $23,053
- Regents of the University of California at Irvine $19,214
- Seattle Children's Hospital, WA $9,400
- Nationwide Children's Hospital, OH $392
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.